Verdict: Side-by-side breakdown using the Bull Rankings model. CCJ scored 29.9, UROY scored 23.0 — CCJ leads.
Compare another set
Different reporting periods. UROY's fundamentals are as of July 2026, but CCJ's are as of December 2025 — a 7-month gap. Growth, margin and valuation figures below therefore describe different windows and aren't strictly like-for-like.
CCJ
Cameco Corporation
Uranium · Quality-Growth
29.9
$88.06 · $38.4B
fundamentals as of
Score gap
6.9
CCJ leads
UROY
Uranium Royalty Corp.
Uranium · Quality-Growth
23
$4.18 · $1.6B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
CheapestUROY11.0x
Strongest balance sheetCCJ0.17
Highest qualityCCJ62 / 100
Largest discount to fair valueUROY-8%
Side by side · every name on one set of axes
The model, pillar by pillar (0–100 each)
CCJ
stronger →← stronger
UROY
62
Qualityreturns · margins · balance sheet
51
50
Growthrevenue & earnings expansion
10
10
Valuevaluation vs sector peers
25
CCJ is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
CCJ
UROY
$390mC
FCF
$208mC
+11.0%B
Rev
—
0.17A-
D/E
0.56B
149.3xD
P/E
11.0xB+
1.92C+
PEG
—
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
Valuation · DCF cross-check
CCJ
UROY
488% above
Price vs fair valuelower is cheaper
8% below
~58%/yr
Growth the price impliesyr-1 FCF growth, fading to 4% · lower = less priced in
~-4%/yr
-85%
1-yr DCF upside
+22%
-83%
5-yr DCF upside
+9%
-80%
10-yr DCF upside
-5%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
CCJ
Why this score
Cyclical growth
Foreign reporter (CAD)
UROY
Why this score
Diluting shareholders
Short track record
The companies
CCJCameco Corporation
Uranium · $88.06 · beta 1.14
Why now
Uranium · market cap $38.4b. Down 35% from 52-week high of $135.24 — deep drawdown territory. Revenue growing +11%, comfortably above the S&P median. 11 sell-side analysts rate this a Buy with a mean 1-yr target of $126.78 (implying +44% upside).
Moat
Net margin 17% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. FCF converts 157% of net income — earnings translate cleanly into cash.
Risk
Trailing P/E 149.3x prices in sustained high growth — any quarter that disappoints triggers sharp re-rating. Down 35% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. P/S 15.7x embeds aggressive forward growth — disappointing top-line guidance would compress the multiple hard.
UROYUranium Royalty Corp.
Uranium · $4.18 · beta 1.58
Why now
Uranium · market cap $1.6b. Down 24% from 52-week high of $5.52 — deep drawdown territory. 3 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $4.19 (implying +0% upside).
Moat
Net margin 26% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close. Free cash flow runs well ahead of reported net income, mostly because of cash released from working capital ($167m, chiefly inventory sold down) — a release that doesn't repeat every year the way earnings can.
Risk
Beta 1.58 implies above-market volatility — position-size to the drawdowns this name will produce in a market correction, not to its bull-case return.
Verdict — model-derived comparison
The model favors CCJ (score 43) primarily due to its significantly higher Growth pillar score of 50 compared to UROY's 10. However, a contrarian might prefer UROY due to its deep discount to fair value at -64% and a much lower implied growth rate of -10%, though investors should note its "Diluting shareholders" signal.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Where CCJ and UROY diverge
On the headline score the gap is 6.9 points in favor of CCJ. They get there differently, though — each leads on a different pillar, so the better pick depends on which you weight.
GrowthCCJ 50.0 · UROY 9.5CCJ +40.5
ValueCCJ 10.1 · UROY 25.4UROY +15.3
QualityCCJ 62.0 · UROY 50.6CCJ +11.4
Pillars run 0–100. Value is judged against each company's own sector, so a Value score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.
Common questions
Is CCJ or UROY the better stock?
CCJ scores higher: CCJ 29.9, UROY 23.0 out of 100 on the Bull Rankings quality-growth score, which blends business quality, growth and valuation into one number. A higher score means a stronger business at a more reasonable price — it is not a price target or a recommendation.
Where do CCJ and UROY differ most?
The widest gap is growth, where CCJ leads by 41 points on the 0–100 pillar scale. Neither name sweeps: they trade the lead across the three pillars, so the comparison is a trade-off rather than one being better on every measure.
How are CCJ and UROY scored?
Each carries the same 0–100 quality-growth score used everywhere on the site, built from three pillars — quality (profitability and returns on capital), growth (revenue and earnings), and value (what you pay for them) — combined as a geometric mean, so a weak pillar cannot be papered over by a strong one.
How current is this comparison?
The whole universe is re-scored every trading day after the US market close, so the scores and fundamentals here reflect the latest published edition.